Use of Dexmedetomidine in Children Undergoing Oral Maxillofacial Surgery to Decrease Emergence Delirium.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 10 May 2017
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 02 Aug 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 16 May 2011 New trial record